Rhythm Pharmaceuticals, Inc. in 1 story
The narratives RYTM currently appears in, with its side and exposure in each.
Bull side
1 story- GLP-1 Eats Everything
RYTM in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
Rhythm markets IMCIVREE for rare genetic obesities and benefits as greater obesity awareness drives genetic testing and diagnosis.
Bear side
0 storiesNo bear-side stories for RYTM yet.